Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Podcast TCTMD Talking Points

The STOPDAPT-3 Trial

October 09, 2024

News Conference News ESC 2023

STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI

Todd Neale

August 26, 2023

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

Presentation EuroPCR 2015

Final Three-Year Outcome of a Randomized Trial Comparing Second Generation DES Using Either Biodegradable Polymer or Durable Polyme

Presenter: Masahiro Natsuaki

May 19, 2015

Presentation ACC 2014

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Presenter: Masahiro Natsuaki

March 31, 2014

News Conference News ACC 2014

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Jason Kahn

March 31, 2014

News Daily News

Un Registro Japonés No halla Beneficio alguno sobre la Mortalidad con PCI de OTC aún cuando las PCI tienen Éxito

Caitlin E. Cox

June 20, 2013

News Daily News

Japanese Registry Finds No Mortality Benefit with CTO PCI Even When Successful

Caitlin E. Cox

June 20, 2013

Presentation

Biodegradable Polymer BES vs. Durable Polymer EES: A Randomized, Controlled, Non-inferiority Trial

Presenter: 221201|Masahiro Natsuaki

May 08, 2013

Presentation ACC 2013

One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Presenter: Masahiro Natsuaki

March 09, 2013

News Conference News ACC 2013

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Jason Kahn

March 09, 2013

Presentation TCT 2012

Statin Therapy Reduces Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Presenter: Masahiro Natsuaki, Takeshi Morimoto, Yutaka Furukawa, Satoshi Shizuta, Toru Kita, Takeshi Kimura

January 03, 2012

Video

» Interview

Beyond the Data: STOPDAPT-3–Is Aspirin-Free an Option?

August 31, 2023

Advertisement

The STOPDAPT-3 Trial

STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI

Trials Explore the Potential of Biodegradable-Polymer Stents

Final Three-Year Outcome of a Randomized Trial Comparing Second Generation DES Using Either Biodegradable Polymer or Durable Polyme

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Un Registro Japonés No halla Beneficio alguno sobre la Mortalidad con PCI de OTC aún cuando las PCI tienen Éxito

Japanese Registry Finds No Mortality Benefit with CTO PCI Even When Successful

Biodegradable Polymer BES vs. Durable Polymer EES: A Randomized, Controlled, Non-inferiority Trial

One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Statin Therapy Reduces Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Beyond the Data: STOPDAPT-3–Is Aspirin-Free an Option?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content